Medical Journals

In Shr Aorta, Calcium Ionophore A-23187 Releases Prostacyclin and Thromboxane A2 As Endothelium-derived Contracting Factors.

Authors:
  • Gluais Pascale
  • Paysant Jerôme
  • Badier-Commander Cécile
  • Verbeuren Tony
  • Vanhoutte Paul M
  • Félétou Michel

From: Département Angiologie, Institut de Recherches Servier, 11 rue des Moulineaux, 92150 Suresnes, France.

American journal of physiology. Heart and circulatory physiology

  • Publish Date: Nov 2006
  • ISSN: 0363-6135
  • Volume: 291
  • Issue: 5
  • Pages: H2255-64
  • Medium: Print
  • Language: English
  • Citation (JAMA): Gluais Pascale, Paysant Jerôme, Badier-Commander Cécile, et al. In Shr Aorta, Calcium Ionophore A-23187 Releases Prostacyclin and Thromboxane A2 As Endothelium-derived Contracting Factors.. Am. J. Physiol. Heart Circ. Physiol. Nov 2006;291:H2255-64

Abstract

In mature spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY), acetylcholine and the calcium ionophore A-23187 release endothelium-derived contracting factors (EDCFs), cyclooxygenase derivatives that activate thromboxane-endoperoxide (TP) receptors on vascular smooth muscle. The EDCFs released by acetylcholine are most likely prostacyclin and prostaglandin (PG)H(2), whereas those released by A-23187 remain to be identified. Isometric tension and the release of PGs were measured in rings of isolated aortas of WKY and SHR. A-23187 evoked the endothelium-dependent release of prostacyclin, thromboxane A(2), PGF(2alpha), PGE(2), and possibly PGH(2) (PGI(2) >> thromboxane A(2) = PGF(2alpha) = PGE(2)). In SHR aortas, the release of prostacyclin and thromboxane A(2) was significantly larger in response to A-23187 than to acetylcholine. In response to the calcium ionophore, the release of thromboxane A(2) was significantly larger in aortas of SHR than in those of WKY. In both strains of rat, the inhibition of cyclooxygenase-1 prevented the release of PGs and the occurrence of endothelium-dependent contractions. Dazoxiben, the thromboxane synthase inhibitor, abolished the A-23187-dependent production of thromboxane A(2) and inhibited by approximately one-half the endothelium-dependent contractions. U-51605, an inhibitor of PGI synthase, reduced the release of prostacyclin elicited by A-23187 but induced a parallel increase in the production of PGE(2) and PGF(2alpha), suggestive of a PGH(2) spillover, which was associated with the enhancement of the endothelium-dependent contractions. These results indicate that in the aorta of SHR and WKY, the endothelium-dependent contractions elicited by A-23187 involve the release of thromboxane A(2) and prostacyclin with a most likely concomitant contribution of PGH(2).

Mesh Headings (Keywords): Animals, Aorta, Thoracic, Calcimycin, Dose-Response Relationship, Drug, Endothelium, Vascular, Epoprostenol, Hypertension, Ionophores, Male, Rats, Rats, Inbred SHR, Rats, Inbred WKY, Thromboxane A2, Vasoconstriction


Check for Full Text / PubMed Unique Identifier (PMID): 16798820


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.